Role of the intracellular receptor domain of gp130 (exon 17) in human inflammatory bowel disease
- PMID: 15754404
- PMCID: PMC4250713
- DOI: 10.3748/wjg.v11.i8.1196
Role of the intracellular receptor domain of gp130 (exon 17) in human inflammatory bowel disease
Abstract
Aim: To study the role of the intracellular receptor domain of gp130 in human inflammatory bowel disease (IBD).
Methods: We amplified and sequenced the complete exon 17 of the human gp130 gene in 146 patients with IBD. According to clinical and histopathological signs, the 146 patients with IBD were classified as having Crohn's disease (n = 73) or ulcerative colitis (n = 63), or as indeterminate status (n = 10).
Results: No mutations in exon 17 of the gp130 gene could be detected in any of the 146 patients with IBD examined.
Conclusion: There is no evidence that mutations in exon 17 of the gp130 gene are involved in the pathogenesis of human IBD.
Figures
References
-
- Vlotides G, Zitzmann K, Stalla GK, Auernhammer CJ. Novel neurotrophin-1/B cell-stimulating factor-3 (NNT-1/BSF-3)/cardiotrophin-like cytokine (CLC)--a novel gp130 cytokine with pleiotropic functions. Cytokine Growth Factor Rev. 2004;15:325–336. - PubMed
-
- Szalai C, Toth S, Falus A. Exon-intron organization of the human gp130 gene. Gene. 2000;243:161–166. - PubMed
-
- Ernst M, Inglese M, Waring P, Campbell IK, Bao S, Clay FJ, Alexander WS, Wicks IP, Tarlinton DM, Novak U, et al. Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med. 2001;194:189–203. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical